Edition:
United States

Biospecifics Technologies Corp (BSTC.OQ)

BSTC.OQ on NASDAQ Stock Exchange Global Market

42.76USD
4:00pm EDT
Change (% chg)

$-1.07 (-2.44%)
Prev Close
$43.83
Open
$43.54
Day's High
$43.54
Day's Low
$42.61
Volume
8,433
Avg. Vol
8,421
52-wk High
$58.36
52-wk Low
$38.12

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Dec '17 6.70 0.512
Sep '17 6.52 0.371
Jun '17 6.54 0.358
Mar '17 7.69 0.460
FY 2016 Dec '16 6.62 0.400
Sep '16 6.88 0.419
Jun '16 6.18 0.354
Mar '16 6.57 0.389
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Jun-18 1 6.57 6.57 6.57 --
Quarter Ending Sep-18 1 6.96 6.96 6.96 --
Year Ending Dec-18 1 28.78 28.78 28.78 35.90
Earnings (per share)
Quarter Ending Jun-18 1 0.44 0.44 0.44 --
Quarter Ending Sep-18 1 0.48 0.48 0.48 --
Year Ending Dec-18 1 2.02 2.02 2.02 2.27
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) 25.76 185.16 33.25
P/E High - Last 5 Yrs. 58.85 283.72 45.98
P/E Low - Last 5 Yrs. 25.53 95.28 24.86
Beta 1.45 0.75 0.80
Price to Sales (TTM) 11.29 137.70 7.20
Price to Book (MRQ) 4.67 19.28 5.06
Price to Tangible Book (MRQ) 4.62 24.18 6.69
Price to Cash Flow (TTM) 21.12 120.88 25.20
% Owned Institutions 58.06 11.42 2.26

Dividends

  Company industry sector
Dividend Yield -- 0.29 1.53
Dividend Yield - 5 Year Avg -- 0.20 0.76
Dividend 5 Year Growth Rate -- 1.94 3.96
Payout Ratio(TTM) 0.00 9.17 20.68

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago 1.22 81.55 8.73
Sales (TTM) vs TTM 1 Yr. Ago 4.54 97.79 11.30
Sales - 5 Yr. Growth Rate 19.75 33.72 8.21
EPS (MRQ) vs Qtr. 1 Yr. Ago 28.19 -66.22 22.52
EPS (TTM) vs TTM 1 Yr. Ago 8.94 -- --
EPS - 5 Yr. Growth Rate 31.79 47.04 10.26
Capital Spending - 5 Yr. Growth Rate -- 45.24 10.40

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.64 2.53
Current Ratio (MRQ) 31.04 6.01 3.61
LT Debt to Equity (MRQ) 0.00 23.49 11.52
Total Debt to Equity (MRQ) 0.00 25.92 14.21
Interest Coverage (TTM) -- -189.88 30.35

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 34.63 54.09
Gross Margin - 5 Yr. Avg. -- 55.35 52.20
EBITD Margin (TTM) 72.58 -- --
EBITD - 5 Yr. Avg 65.95 -153.57 15.86
Operating Margin (TTM) 64.42 -573.06 3.97
Operating Margin - 5 Yr. Avg. 61.02 -165.53 11.17
Pre-Tax Margin (TTM) 66.92 -545.71 4.62
Pre-Tax Margin - 5 Yr. Avg. 62.23 -172.26 11.49
Net Profit Margin (TTM) 45.29 -534.59 1.24
Net Profit Margin - 5 Yr. Avg. 41.32 -172.04 7.83
Effective Tax Rate (TTM) 32.33 -0.67 31.24
Effective Tax Rate - 5 Yr. Avg. 33.61 18.14 24.26

Efficiency

  Company industry sector
Revenue/Employee (TTM) 5,488,752 23,627,894 806,826,037
Net Income/Employee (TTM) 2,485,652 954,925 94,789,739
Receivable Turnover (TTM) 6.48 6.54 5.54
Inventory Turnover (TTM) -- 2.39 3.44
Asset Turnover (TTM) 0.39 0.40 0.88

Management Effectiveness

  Company industry sector
Return on Assets (TTM) 17.79 -0.73 10.47
Return on Assets - 5 Yr. Avg. 20.51 0.66 11.49
Return on Investment (TTM) 18.34 -0.71 13.13
Return on Investment - 5 Yr. Avg. 21.08 4.08 14.88
Return on Equity (TTM) 20.08 -2.76 14.96
Return on Equity - 5 Yr. Avg. 22.10 -0.32 16.18
  1 Year 3 Year 5 Year
Sales % 4.54 25.02 19.75
EPS (TTM) % 8.71 37.27 31.79
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Biospecifics Technologies Corp

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 58.05%
# of Holders: 133
Total Shares Held: 4,179,454
3 Mo. Net Change: -88,558
# New Positions: 0
# Closed Positions: 3
# Increased Positions: 4
# Reduced Positions: 10
# Net Buyers: -6
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.